US Stock MarketDetailed Quotes
VNDA Vanda Pharmaceuticals
- 5.090
- +0.150+3.04%
Close Nov 22 16:00 ET
- 5.010
- -0.080-1.57%
Post 20:01 ET
296.79MMarket Cap-17551P/E (TTM)
5.160High4.900Low587.66KVolume4.930Open4.940Pre Close2.97MTurnover1.12%Turnover Ratio127.25P/E (Static)58.31MShares6.75052wk High0.55P/B267.84MFloat Cap3.46052wk Low--Dividend TTM52.62MShs Float33.440Historical High--Div YieldTTM5.26%Amplitude0.450Historical Low5.047Avg Price1Lot Size
About Vanda Pharmaceuticals Company
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
Company Profile
SymbolVNDA
Company NameVanda Pharmaceuticals
Listing DateApr 12, 2006
Issue Price10.00
Founded2002
CEODr. Mihael Hristos Polymeropoulos,M.D.
MarketNASDAQ
Employees203
Fiscal Year Ends12-31
Address2200 Pennsylvania Avenue NW,Suite 300E
CityWashington
ProvinceDistrict of Columbia
CountryUnited States of America
Zip Code20037
Phone1-202-734-3400
Websitehttp://www.vandapharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Mihael Hristos Polymeropoulos,M.D.
- Chairman of the Board, President and Chief Executive Officer
- 3.72M
- Kevin Moran
- Senior Vice President, Principal Accounting Officer, Chief Financial Officer and Treasurer
- 1.32M
- Joakim Wijkstrom
- Senior Vice President and Chief Marketing Officer
- 1.36M
- Timothy Williams
- Senior Vice President, General Counsel and Secretary
- 1.40M
- Gunther Birznieks
- Senior Vice President, Business Development
- 1.37M
- Richard W. Dugan
- Lead Independent Director
- 332.50K
- Anne Sempowski Ward
- Independent Director
- 302.50K
- Tage Honore
- Independent Director
- 602.43K
- Stephen Ray Mitchell
- Independent Director
- 282.50K
- Phaedra Chrousos
- Independent Director
- 300.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data